KATHRYN WRIGHT: Open Payments
NPI 1962028258 · LAKE ODESSA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 31 payments from 8 companies in 2025. Trend: 2023 $1,193 · 2024 $820 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $270 |
| Supernus Pharmaceuticals, Inc. | 9 | $136 |
| Novo Nordisk Inc | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Lilly USA, LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Verona Pharma, Inc. | 1 | $16 |
Products named: VRAYLAR, Qelbree, QULIPTA, AIRSUPRA, Ozempic, MOUNJARO, The Cologuard Plus Collection Kit, Wegovy.
Industry payments across MI — which companies pay providers there.
